1056-144 Multiexpert blinded interpretation of electrocardiogram-gated SPECT imaging in women: Relative performance of thallium-201 and technetium-99m sestamibi  by Bateman, Timothy M et al.
JACC March 3, 2004 ABSTRACTS - Noninvasive Imaging  323A
Noninvasive Im
aging
1055-156 Assessment of Renal Artery Stenosis by 3-D Contrast-
Enhanced and 3-D Phase-Contrast Magnetic Resonance 
Angiography: A Comparison With Conventional X-Ray 
Angiography
Juan Carlos Rozo, Scott Flamm, Brenda Lambert, Vei-Vei Lee, Eduardo Hernandez, St. 
Luke's Episcopal Hospital/Texas Heart Institute, Houston, TX
Background: The purpose of this study was to evaluate the sensitivity and specificity of
magnetic resonance angiography (MRA) using the combination of 3-D contrast-
enhanced and 3-D phase-contrast imaging as a non-invasive diagnostic modality in
patients with suspected renovascular hypertension when compared with conventional x-
ray angiography.
Methods: 134 patients underwent renal MRA prior to conventional x-ray angiography
were evaluated. Most patients were referred for MRA for further evaluation of renal insuf-
ficiency or difficult to control hypertension. MRAs were blindly evaluated independently
by a single radiologist, and renal arteriograms were evaluated by a single interventional
cardiologist.
Results: After exclusion of 19 renal arteries (7% of total renal arteries) due to prior stent-
ing or lack of selective cannulation during angiography, a total of 249 main renal arteries
were available for comparison. Polar arteries and branches were excluded from the anal-
ysis. The sensitivity and specificity for significant main renal artery stenosis defined as
narrowing of > 50 % was 90% and 91%, respectively. The positive and negative predic-
tive values were 86 % and 94 %, respectively. The Pearson correlation coefficient was
0.84 (Prob > [r] under HO: RHO=0) for MRA when compared to conventional angiogra-
phy.
Conclusion: Magnetic resonance angiography using the combination of 3-D contrast-
enhanced and 3-D phase-contrast imaging is an excellent diagnostic tool in the assess-
ment of patients with suspected renal artery stenosis.
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1056-141 Is There Value in Follow-Up Stress Testing for 
Emergency Department Patients With Chest Pain and 
Normal Rest SPECT Myocardial Perfusion?
Prem Soman, Joni R. Beshanksky, Robin Ruthazer, John L. Griffith, Gary V. Heller, 
Robert C. Hendel, J.Hector Pope, Ethan J. Spiegler, James A. Feldman, Harry P. Selker, 
James E. Udelson, Tufts-New England Medical Center, Boston, MA
Background: Normal rest myocardial perfusion imaging (MPI) in the emergency depart-
ment (ED) is associated with a high negative predictive value for acute MI and ischemia,
but how often follow-up testing is useful has not been studied.
Methods: The ERASE Chest Pain trial randomized 2,475 ED patients with suspected
cardiac ischemia, no prior MI, and a non-diagnostic ECG to usual care, or care aided by
the results of rest MPI, to determine the effect of the latter strategy on ED triage. A proto-
col-directed follow-up stress test was performed within 2 weeks (median 4 days) of the
initial ED scan in 457 pts with a normal resting ED MPI in pts with no cardiac events. Of
these, 123 (26%), 292 (63%) and 42 (9%) had treadmill exercise ECG testing only, exer-
cise MPI, and pharmacological stress MPI, respectively.
Results: Stress tests were classified as definitely normal, definitely abnormal, non-spe-
cific or non-diagnostic. 43 pts (9%) demonstrated ischemia on stress testing, while 380
(80%) were classified as definitely normal. Using stepwise multivariable regression, age
and known prior coronary artery disease (CAD) were found to be the clinical variables
that predicted the presence of abnormal stress testing after normal rest MPI (p = 0.004
and 0.006, respectively). There was an interaction between age and CAD: among pts
without prior CAD, the odds of an abnormal stress test increased with age (OR=1.5 per
10 year increase, p=0.0037), while among pts with prior CAD, there was no relationship
between age and abnormal follow-up stress test (OR=0.79 per 10 year increase,
p=0.39). Gender, history of diabetes, presence of chest pain during tracer injection for
the ED scan, and presence of symptoms in the ED did not influence the prevalence of
ischemia on follow-up stress testing.
Conclusion: A small but significant percentage of ED patients with suspected cardiac
ischemia and normal resting MPI have abnormal subsequent stress testing. While nor-
mal resting MPI in such patients predicts a good short-term outcome as established in
the ERASE Chest Pain and other trials, the presence of inducible ischemia on subse-
quent stress testing may define prognosis in the longer term, and have therapeutic impli-
cations.
1056-142 Investigation of Myocardial-Gated SPECT Imaging as an 
Initial Strategy in Heart Failure: The IMAGING in Heart 
Failure Study
Prem Soman, A. Lahiri, J. Mieres, D. Calnon, D. Wolinsky, G. A. Beller, T. Sias, K. 
Burnham, L. Conway, P. McCullough, E. Daher, M. N. Walsh, J. Wight, G. V. Heller, J. E. 
Udelson, Tufts-New England Medical Center, Boston, MA
Background: Few data exist on the prevalence of differing pathophysiologies for the initial
presentation of heart failure (HF). Methods: The IMAGING in HF trial was designed to
define the role of myocardial perfusion imaging (MPI) as an early evaluation strategy for
HF. Pts were included if they were hospitalized for first presentation of HF, fulfilled the
Framingham Study HF criteria and did not have an acute MI. Stress/rest gated SPECT
Tc-99m sestamibi imaging was performed in all pts, interpreted blindly in a central lab
and scored semi-quantitatively. Catheterization was performed based on all clinical and
imaging data.
Results: 201 pts were enrolled at 14 centers, of whom 43% were women, 65% had no
previous history of coronary artery disease (CAD), and 34% had diabetes. Stress testing
was pharmacological in 87%. LV EF was > 40% in 36%, a proportion similar to that seen
in chronic HF. Perfusion data: see Table. Among the 37% of patients who underwent cor-
onary arteriography, MPI had a 91% sensitivity, 60% specificity and 89% negative predic-
tive value (NPV) for significant CAD.
Conclusions: Gated SPECT MPI with initial presentation of HF demonstrates a distribu-
tion of ejection fractions similar to that seen in chronic HF. Extensive reversible ischemia
is present in a minority of patients, with similar prevalence in pts with preserved vs
impaired EF. Normal perfusion is seen in ~ 40%, and has a high NPV for excluding CAD.
1056-143 Standard Right Ventricular Apical Pacing Associated 
With Deterioration of Left Ventricular Function
James H. O'Keefe, Jr., Randall C. Thompson, Ravindra Kahatapitiya, Phillip G. Jones, 
Brian M. Ramza, David M. Steinhaus, Mid-America Heart Institute, Kansas City, MO
Abstract
Left ventricular (LV) ejection fraction (EF) has a powerful influence on outcome and car-
diovascular disease. We used a comprehensive prospect of nuclear database to assess
determinance of substantial improvement or deterioration in LV function over time. A total
of 17,000 consecutive patients were queried to identify patients with serial gated rest and
stress single-photon emission computed tomography (SPECT) studies at least 6 months
apart. We included only patients whose LVEF rose greater than or equal to 10 points or
fell 7 points or more. Both univariable and multivariable analyses were performed to iden-
tify significant correlates of change in LVEF over time. A total of 148 patients had EF
increase greater than or equal to 10 and 50 patients had EF decrease greater than or
equal to 7. Only patients whose baseline LVEF was between 25% and 40% were
included in the analysis. LVEF on average rose from 33% to 51% in the EF increase
group and fell from 35% to 25% in the EF decrease group. The only multivariable predic-
tor of improvement in LVEF was the use of beta blocker therapy (odds ratio 0.227, confi-
dence limits 0.09-0.050, p=0.0003). The only multivariable predictor of deterioration of LV
function was presence of a pre-existing right ventricular apical pacemaker (odds ratio
=5.4, confidence limits 1.66-19.4, p=0.006).
Conclusion
The strongest correlate of chronic improvement in LVEF was use of beta blocker therapy.
In contrast, the only significant independent predictor of deteriorating LV function over
time was use of right ventricular apical pacing. These variables should be considered
when choosing therapy for patients with depressed left ventricular ejection fraction.
1056-144 Multiexpert Blinded Interpretation of Electrocardiogram-
Gated SPECT Imaging in Women: Relative Performance 
of Thallium-201 and Technetium-99m Sestamibi
Timothy M. Bateman, Frans JTh Wackers, Jennifer H. Mieres, Kelly L. Moutray, James A. 
Case, Ginger J. Hertenstein, John A. House, S James Cullom, Mid America Heart 
Institute, Kansas City, MO, Cardiovascular Imaging Technologies, Kansas City, MO
Background: Contemporary SPECT myocardial perfusion imaging emphasizes the
importance of image quality and ECG-gating. No recent analysis of comparative accu-
racy related to choice of radionuclide has been undertaken. We studied relative perfor-
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mance of gated Thallium-201 (Tl) and Tc-99m sestamibi (MIBI) in 302 women,
hypothesizing that advances in technology and imaging protocols would negate impor-
tance of radionuclide choice.
Methods: 3 experienced readers, blinded to all clinical information, scored 604 randomly
presented non-gated and gated SPECT scans in 302 women - 152 imaged with Tl and
150 with MIBI. Patients were imaged using LEAP (Tl) or LEHR (MIBI) collimators, dual
90o detectors and weight-adjusted dosages of Tl (3.0-4.5 mCi) and MIBI (25-40 mCi). Tl
images were acquired using a previously described time-adjusted acquisition according
to counts from a pre-scan planar image. Body mass index (BMI) was 30+/-7 (range 16 -
47) and age 63+/-12 years. There were 101 (33%) low likelihood women and 201 had
cath < 60 days (0 VD 61(30%), SVD 72 (36%), MVD 68 (34%)). Multivariate statistical
analysis was performed for relative sensitivity, specificity, and normalcy of the 2 radionu-
clides, after controlling for age, type of stress, BMI, CAD distribution, and image quality.
Results: Image quality (Tl vs MIBI) was excellent in 92% vs 90% (p=NS). Interpretive
certainty improved for both tracers with gating: 70% definitely normal or abnormal without
vs 79% with gating (p=0.05). ECG-gated SPECT tracer-combined normalcy was 92%,
sensitivity 86% and specificity 66%. Logistic analysis showed no significant difference
between the radionuclides for correctly recognizing low likelihood or cath normals, but Tl
had higher sensitivity for CAD detection (p=0.0004).
Conclusion: This large blinded interpretive study of SPECT scanning in women demon-
strated that contemporary SPECT provides high quality images independent of tracer
and that ECG-gating improves interpretive certainty for both Tl and MIBI. Normalcy and
specificity appear independent of radionuclide, BMI, type of stress, and age of patient.
After controlling for these variables, Tl had higher sensitivity for detection of CAD in
women.
1056-157 Serial Testing With Rest/Stress Tc-99m Sestamibi 
Myocardial Perfusion Imaging: Normal Results Provide 
an Extended Warranty
Gavin L. Noble, Sachin M. Navare, Deb Katten, Alan W. Ahlberg, Michael Platt, William 
E. Boden, Gary V. Heller, Hartford Hospital, Hartford, CT
Background: Patients with known or suspected CAD with normal rest/stress Myocardial
Perfusion Imaging (MPI) have low cardiac event rates (1%/yr), a “Warranty Period” of 2-3
years. Cardiac risk after repeat symptom-guided testing has not been evaluated.
Objective: To evaluate the impact of repeat symptom-guided MPI in patients with prior
normal MPI upon subsequent risk stratification.
Methods: The database of rest/stress Tc-99m sestamibi MPI at Hartford Hospital from
1996-2001 was queried for patients with multiple studies whose first study was normal
(N= 694) and those with a single study (N= 9587). Patients were prospectively followed
for cardiac death/non-fatal MI (23.6 +/- 12.8 months after repeat test, and 25 +/- 14.6
after single test). The inter-test interval was 798 +/- 462 days. MPI was classified as nor-
mal or abnormal (fixed and reversible). No patients had MI between tests.
Results: Patients who remained normal on repeat testing had a very low cardiac event
rate (11/526), similar to patients with only 1 normal test (86/6192) 1.1%/year vs. 0.9%/
year p=NS. Patients who converted to abnormal had an increased event rate (13/168)
similar to those with only one abnormal test (234/3395) 3.9%/year vs. 3.3/year p=NS.
Conclusion: Repeat testing of symptomatic patients with known or suspected CAD with
prior normal MPI is an effective means of further risk stratification. The “Warranty Period”
for patients extends approximately 2 years after the most recent normal symptom guided
MPI.
1056-158 Stability of Right and Left Ventricular Ejection Fractions 
and End-Diastolic Volumes After Heart Transplantation
Rebecca P. Streeter, Kenneth Nichols, Steven R. Bergmann, Columbia University, New 
York, NY
Background: Acute changes in RV pressure early after heart transplantation have been
well described and pulmonary resistance predicts early graft viability. Additionally,
changes in LVEF are known to accompany the development of graft vasculopathy and
rejection. However, the long-term stability of the RV and LV size and function have not
been well characterized. We have recently validated the ability to accurately measure RV
and LV EF and volumes with SPECT equilibrium radionuclide ventriculography (RVG).
The objective of this study was to assess time- and rejection-dependent changes in RV
and LV function following cardiac transplantation.
Methods: 71 consecutive patients (mean age 57 +/- 12 (SD) years, 62M/9F) were stud-
ied 61 +/- 47 months (range 11-193) after heart transplantation. The mean frequency of
>grade 2 rejection was 1.7 +/- 1.8 episodes (range 0-7). RV and LV EF and end-diastolic
volume (EDV) in patients were compared with 34 subjects at low likelihood for CAD
(mean age 52 +/- 16 years, 11M/23F).
Results: Although RV EDV was slightly higher in patients with heart transplants, no sig-
nificant differences in RV or LV EF or EDV compared with controls were observed.
Conclusion: Although acute RV failure decreases survival in the early post transplant
period, RV as well as LV EF and EDV are stable greater than 1 year after heart transplan-
tation for up to 16 years. Thus, changes in EF or EDV in the transplanted heart are abnor-
mal and should prompt a clinical evaluation. 
1056-159 Prognostic Utility of SPECT in Adult Patients With 
Hypertrophic Cardiomyopathy
Paul Sorajja, Panithaya Chareonthaitawee, Steve Ommen, Todd Miller, Dave Hodge, 
Raymond Gibbons, Mayo Clinic and Mayo Foundation, Rochester, MN
Background.Data derived from stress myocardial perfusion imaging (MPI) carries prog-
nostic significance in young patients with hypertrophic cardiomyopathy (HCM), but there
are limited data on its utility in those who are older.
Methods and Results. Between January 1986 and September 2000, 158 patients (96
men) with HCM who were aged >18 years (mean, 60 yrs) underwent exercise or pharma-
cologic stress MPI. Using a 14 myocardial segment model with 5 perfusion grades
(absent = 0 to normal perfusion = 4), the summed stress score (SSS) and summed
reversibility score (SRS) were calculated for each patient. Follow-up was 99% complete
in 157 patients at a median duration of 5.2 yrs. Ten-year unadjusted cardiovascular sur-
vival was poorer in HCM patients with abnormal stress MPI (67% [95% CI, 53 to 85%]
than among those with normal studies 89% [80 to 100%]; p=0.04). The continuous vari-
ables of SSS (hazard ratio, 0.93; 95% CI, 0.88 to 0.98; p=0.01) and SRS (1.08, 1.01 to
1.16; p= 0.04) were both also univariate predictors of cardiac death.
Conclusions. In a predominantly older population of patients with HCM, stress MPI iden-
tifies those at increased risk of cardiovascular death. Patients with HCM who have nor-
mal stress MPI have an annual risk of cardiovascular death of 1.1%, only slightly higher
than that reported for less selected patients with suspected CAD and normal MPI.
1056-160 Myocardial Sympathetic Denervation Precedes the 
Neurological Involvement in Patients With Familial 
Amyloidotic Polyneuropathy
M. c. Azevedo Coutinho, I. Conceição, A. Almeida, G. Cantinho, E. I. Oliveira, A. 
Bernardes, M. C. Vagueiro, Santa Maria Hospital, Lisbon, Portugal
Background: Familial amyloidotic polyneuropathy (FAP) type I is a rare hereditary form
of amyloidosis characterized by polyneuropathy and progressive autonomic nervous sys-
tem dysfunction. Cardiovascular manifestations are due to amyloid deposits in the heart
and to the autonomic dysfunction. The aim of this study was to assess the cardiac
involvement in FAP patients and to correlate the findings with the neurological status.
Methods: 45 patients with FAP (mean age = 43 ± 14 years) underwent I123-metaiodo-
benzylguanidine (MIBG) myocardial scintigraphy, in order to evaluate sympathetic inner-
vation, ambulatory blood pressure monitoring (ABPM), 24 hour Holter and
echocardiography. The neurological involvement was quantified according to an elec-
tromyographic score (0-100%; 0 = no abnormality, 100% = maximal incapacity)
Results: The MIBG uptake was 1.8 ± 0.5 (normal = 2.6 ± 0.3) and correlated inversely
with the EMG score (r = -0.81; p = 0.0001). Thirty-nine (87 %) patients had a decrease in
MIBG activity, 23 (51 %) abnormal circadian BP pattern and 23 (51 %) conduction distur-
bances or arrhythmias. Finally 21 (46%) patients showed septal thickness increase and/
or diastolic dysfunction. Thirty patients were symptomatic with an EMG score of 38 ± 24
% (group I) and the remaining 15 were asymptomatic [EMG score = 0 (group II) ].
Patients in the group I were older (46 ± 14 vs. 36 ± 12 years, p = 0.02), had lower MIBG
uptake (1.6 ± 0.4 vs. 2.1 ± 0.3, p = 0.0001), higher systolic (117 ± 17 vs. 104 ± 5 mm Hg,
p = 0.006) and diastolic BP at night (70 ± 12 vs. 60 ± 5 mm Hg, p = 0.002) and higher
septal thickness (12 ± 2 vs. 9 ± 2 mm, p = 0,001) than patients in group II.
Cardiac MIBG uptake was decreased in 28/30 patients in the group I and in 11/15 in the
group II. ABPM and Holter recording were both altered in 21 patients in group I and in 2
in group II. Septal thickness was increased in only one asymptomatic patient, being the
others symptomatic.
Conclusions: Patients with FAP have a high incidence of myocardial sympathetic dener-
vation that often antedate the development of neurologic and cardiac impairment. This
finding may be useful to determine the timing for liver transplantation, which is nowadays
the only way to control the progression of the disease.
Controls (n=34) Transplant (n=71) p
RVEF 54 +/- 9 53 +/- 9 NS
RVEDV (ml) 109 +/- 35 120 +/- 32 NS
LVEF 72 +/- 8 73 +/- 9 NS
LVEDV (ml) 108 +/- 28 98 +/- 20 NS
